RecallDepth
Class II Terminated

Cephalexin for Oral Suspension, USP, 125 mg per 5 mL, packaged as a) 100 ml (when mixed) bottle, NDC 67877-544-88; b) 200 ml (when mixed) bottle NDC 67877-544-68, Rx Only, Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA. Distributed by: Ascend Lab,oratories, LLC Parsippany, NJ 07054

This recall has been terminated (originally issued January 13, 2021).

Company
Ascend Laboratories, Llc
Recall Initiated
November 23, 2020
Posted
January 13, 2021
Recall Number
D-0185-2021
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
20,232 bottles
Firm Location
Parsippany, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Impurity/Degradation Specifications: Unidentified impurities not complying with specifications were observed in various lots of Cephalexin FOS USP 125 mg/5 mL.

Distribution

Distributed Nationwide in the USA

Lot / Code Info

Lot#: a) 19144340, 19144341, Exp AUG 2021; b) 20142226, 20142227, Exp MAY 2022

More recalls by Ascend Laboratories, Llc

View all recalls by this company →

Other recent Class II Drug recalls